Updated on December 8, 2023

The Epilogue of NIB research should lead to technology transfer (TT) to companies adopting NIB prototypes (biomedical equipment or medical informatics applications).In this way the clinical needs initially defined with clinical groups are available for use and continuous improvement in the health systems of Uruguay and other countries.

FINANIB Patents, utility models and trademarks:
DINABANG trademark - applied for DNPI (Act Nº 504494) by the UPI, Central University Research.
DINABANG utility model - pending response from DNPI (Act Nº 4792) by UPI, Central University Research.

Companies collaborating with NIB: